✦ LIBER ✦

Parkinson's disease, insulin resistance and novel agents of neuroprotection

✍ Scribed by Aviles-Olmos, I.; Limousin, P.; Lees, A.; Foltynie, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P1.050 Novel neuroprotective agents for

✍ J. George; S. Wilkins; N. Critch; L. Gunawan; M. Cortes; X. Liu; K. Laughton; M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 75 KB

Neuroprotective agents in Parkinson's di

✍ Hälbig, Thomas D.; Tse, Winona; Olanow, C. Warren 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 248 KB

PL.02.01 Novel therapeutic targets for n

✍ Björklund, A. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Rationale for the use of dopamine agonis

✍ Anthony H. V. Schapira; C. Warren Olanow 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Estrogen, neuroinflammation and neuropro

✍ M.C. Morale; P.A. Serra; F. L’Episcopo; C. Tirolo; S. Caniglia; N. Testa; F. Gen 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 595 KB

Parkinson's Disease and Free Radicals :

✍ TOMOYOSHI KONDO 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 509 KB